ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Mangoceuticals Inc

Mangoceuticals Inc (MGRX)

0.2157
0.0007
(0.33%)
Closed October 10 4:00PM
0.22
0.0043
(1.99%)
After Hours: 7:56PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.22
Bid
0.21
Ask
0.225
Volume
700,042
0.2087 Day's Range 0.2242
0.143 52 Week Range 1.12
Market Cap
Previous Close
0.215
Open
0.2089
Last Trade Time
Financial Volume
$ 148,538
VWAP
0.212185
Average Volume (3m)
4,174,813
Shares Outstanding
29,905,803
Dividend Yield
-
PE Ratio
-0.71
Earnings Per Share (EPS)
-0.31
Revenue
731k
Net Profit
-9.21M

About Mangoceuticals Inc

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was i... Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc. Show more

Sector
Health & Allied Services,nec
Industry
Health & Allied Services,nec
Website
Headquarters
Dallas, Texas, USA
Founded
-
Mangoceuticals Inc is listed in the Health & Allied Services sector of the NASDAQ with ticker MGRX. The last closing price for Mangoceuticals was $0.22. Over the last year, Mangoceuticals shares have traded in a share price range of $ 0.143 to $ 1.12.

Mangoceuticals currently has 29,905,803 shares outstanding. The market capitalization of Mangoceuticals is $6.43 million. Mangoceuticals has a price to earnings ratio (PE ratio) of -0.71.

MGRX Latest News

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

Dallas, Texas, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (β€œMangoRx” or the β€œCompany”), a company focused on developing, marketing, and selling men’s health and...

Healthcare Shares Rise Following Product Availability Announcement

A Texas-based healthcare company is dominating Tuesday’s session after the company announced its oral semaglutide branded as “Slim” is now available on their To read the full...

MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral SemaglutideΒ for Advanced Weight Loss Treatment

MangoRx aims to capitalize on growing demand for GLP-1 treatments to drive revenue growth and expand market share in the weight loss category Dallas, Texas, Oct. 01, 2024 (GLOBE NEWSWIRE...

MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024

Dallas, Texas, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (β€œMangoRx” or the β€œCompany”), a company focused on developing, marketing, and selling a variety of men’s...

MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent

Dallas, Texas, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (β€œMangoRx” or the β€œCompany”), a company focused on developing, marketing, and selling a variety of men’s...

MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide

Dallas, Texas, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (β€œMangoRx” or the β€œCompany”), a company focused on developing, marketing, and selling a variety of men’s...

MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology

Dallas, Texas, July 24, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (β€œMangoRx” or the β€œCompany”), a leader in men’s health and wellness products including erectile dysfunction...

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

DALLAS, TEXAS, July 18, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company”), a company focused on developing, marketing, and selling a variety of men’s...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.051-18.81918819190.2710.3110.18923755290.22654542CS
4-0.0453-17.07500942330.26530.51060.189112352820.29321042CS
12-0.2-47.6190476190.420.51060.18941748130.29695447CS
26-0.0609-21.68031327870.28091.120.18947157030.40492621CS
52-0.3335-60.25293586270.55351.120.14327551250.40112764CS
156-3.98-94.76190476194.24.26940.14322886790.66451535CS
260-3.98-94.76190476194.24.26940.14322886790.66451535CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BLMZBloomZ Inc
$ 1.3301
(85.98%)
81.21M
MLGOMicroAlgo Inc
$ 0.371
(47.22%)
203.6M
XHGXChange TED Inc
$ 0.2454
(37.09%)
220.29M
RNAZTransCode Therapeutics Inc
$ 0.7294
(34.85%)
4.39M
CNEYCN Energy Group Inc
$ 0.7096
(34.70%)
27.04M
GRTSGritstone bio Inc
$ 0.062
(-68.75%)
151.26M
CLIKClick Holdings Ltd
$ 1.50
(-43.18%)
1.22M
MNTSMomentus Inc
$ 0.6376
(-39.85%)
29.57M
CETXCemtrex Inc
$ 0.46
(-35.21%)
16.03M
DUOFangDD Network Group Ltd
$ 1.215
(-30.97%)
24.74M
JTAIJet AI Inc
$ 0.08135
(-12.15%)
810.75M
NVDANVIDIA Corporation
$ 134.81
(1.63%)
242.19M
XHGXChange TED Inc
$ 0.2454
(37.09%)
220.29M
MLGOMicroAlgo Inc
$ 0.371
(47.22%)
203.6M
GRTSGritstone bio Inc
$ 0.062
(-68.75%)
153.39M

MGRX Discussion

View Posts
KeepItRealistic KeepItRealistic 7 days ago
$MGRX mega news below (huge market)

Market Correction incoming…

β€œDallas, Texas, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (β€œMangoRx” or the β€œCompany”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform, announces the release of its latest innovation, β€œTRIM,” a compounded, oral dissolvable Tirzepatide tablet. Available for purchase at $399 per month, this new product offers patients an advanced and convenient alternative to injectable therapies.

Tirzepatide, a dual GIP and GLP-1 receptor agonist, has gained widespread recognition for its effectiveness in promoting substantial weight loss by enhancing metabolic functions and controlling appetite. Clinical trials have shown that Tirzepatide can deliver weight reductions of up to 20% in obese individuals. The phase 3 SURMOUNT-1 clinical trial showed that a significant percentage of participants achieved weight loss of over 15-20% in just 72 weeks, marking it as a viable option and alternative for effective, long-term weight management?.

Further, in the SURMOUNT-4 trial, Tirzepatide not only helped patients achieve substantial weight loss, but it also helped patients maintain their progress over an extended period. After 88 weeks of treatment, patients experienced a total weight reduction of up to 25%, with nearly 90% maintaining at least 80% of their initial weight loss?.

MangoRx’s TRIM formulation now provides Tirzepatide treatment in an easy-to-use oral dissolvable tablet, eliminating the need for injections and enhancing patient convenience.

The launch of TRIM is a key strategic move for MangoRx, as the Company looks to strengthen its foothold in the expanding weight management sector. As demand for non-invasive, clinically proven solutions rises, we believe MangoRx is positioned to capitalize on this market growth.

Jacob Cohen, CEO and Founder of MangoRx, stated, β€œWe are excited to bring TRIM to market, offering consumers a cutting-edge, oral alternative to conventional weight loss injections. TRIM’s introduction marks another significant step for MangoRx as we continue to innovate and meet the changing needs of patients. By launching TRIM, we are delivering a solution that enhances patient convenience without sacrificing efficacy. As demand for GLP-1-based treatments continues to climb, our telemedicine platform ensures that patients have access to safe, reliable options.”

According to a study performed by Roots Analysis, the global GLP-1 market is projected to grow from $49.3 billion in 2024 to $157.5 billion by 2035, with the obesity segment expected to capture the majority share by 2035, due to rising obesity rates and demand for effective treatments.

With the addition of TRIM, MangoRx now offers patients both Tirzepatide and Semaglutide options for weight loss treatments. Following the successful release of our Semaglutide-based oral dissolvable tablet branded as SLIM, patients can choose from two advanced, highly effective GLP-1 receptor agonists, each tailored to meet different needs in their weight management journey. Both products are currently listed on the MangoRx website and available with a doctor’s prescription, providing expanded access to cutting-edge weight loss solutions through its telemedicine platform.”





πŸ‘οΈ0
KeepItRealistic KeepItRealistic 1 week ago
β€œOn October 1, 2024, the Company delivered an Advance Notice to the Purchaser and sold the Purchaser 2,000,000 shares of common stock pursuant to the terms of the ELOC for $0.26 per share for a total of $521,016, net of fees, discounts and expenses”
πŸ‘οΈ0
KeepItRealistic KeepItRealistic 1 week ago
$MGRX company has been selling shares which explains the retrace

https://www.otcmarkets.com/filing/html?id=17875545&guid=9OL-kaoudyTyDVh
👍 1
Penny chatter Penny chatter 1 week ago
Looks like this guy is just a promoter
πŸ‘οΈ0
power11 power11 1 week ago
AS THEY SAY IN ITALIAN : PUMPO AND DUMPO !!!!
PURE DOG SHIT WRAPPED IN CAT SHIT
👍 1
TrendTrade2016 TrendTrade2016 1 week ago
dilute dilute...drop like a rock into open
πŸ‘οΈ0
glenn1919 glenn1919 1 week ago
MGRX..............................https://stockcharts.com/h-sc/ui?s=MGRX&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
FROZENFLAME FROZENFLAME 1 month ago
Thin L2 !
πŸ‘οΈ0
FROZENFLAME FROZENFLAME 1 month ago
It’s moving, waiting on more volume !
πŸ‘οΈ0
mining101 mining101 2 months ago
Big week upcoming
πŸ‘οΈ0
glenn1919 glenn1919 2 months ago
MGRX..........................https://stockcharts.com/h-sc/ui?s=MGRX&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Penny2Dime Penny2Dime 3 months ago
Nice!
πŸ‘οΈ0
KeepItRealistic KeepItRealistic 3 months ago
$MGRX huge

$MGRX de-registers/cancels 13 mil shares from previous S-1. pic.twitter.com/fagVdrN20M— ScalpIt (@nxtplse) July 26, 2024

πŸ‘οΈ0
mining101 mining101 3 months ago
New highs are in sight
πŸ‘οΈ0
KeepItRealistic KeepItRealistic 3 months ago
$MGRX more solid news

https://ca.finance.yahoo.com/news/mangorx-initiates-efficacy-studies-patented-121500395.html
πŸ‘οΈ0
KeepItRealistic KeepItRealistic 3 months ago
$MGRX game changer

https://stocktwits.com/RandySays/message/580033852

πŸ‘οΈ0
KeepItRealistic KeepItRealistic 3 months ago
$MGRX like what I heard…

πŸ‘οΈ0
KeepItRealistic KeepItRealistic 3 months ago
$MGRX keep your 👀 on it for follow up on …

https://finance.yahoo.com/news/mangorx-introduce-oral-semaglutide-tirzepatide-123000451.html

β€œMangoRx plans to have the products available for customers on the company’s telemedicine platform in the beginning of the 3rd quarter with β€˜Slim’ and β€˜Trim’ competitively priced at $299/month and $399/month, respectively. MangoRx is committed to advancing the treatment of obesity and related conditions and is dedicated to improving the lives of patients worldwide.”

3rd Qtr started July 1st

This was the news that pushed it past $1
πŸ‘οΈ0
mining101 mining101 3 months ago
Break .50 soon
πŸ‘οΈ0
glenn1919 glenn1919 3 months ago
MGRX........................https://stockcharts.com/h-sc/ui?s=MGRX&p=W&b=5&g=0&id=p86431144783






πŸ‘οΈ0
Invest-in-America Invest-in-America 3 months ago
MGRX: For their next "news", maybe MGRX can get a pre-fight promo going to the effect that both Jake Paul & Mike Tyson use their stuff!!
πŸ‘οΈ0
mining101 mining101 3 months ago
Rebound to 1
πŸ‘οΈ0
Zardiw Zardiw 3 months ago
I'm wondering if you're pissed off at me for some reason.....can't PM........but whatever it is, I'm sorry if I did/said anything that you didn't like.....

Hans@DDAmanda.com
760 702-2009

Z
πŸ‘οΈ0
Invest-in-America Invest-in-America 3 months ago
MGRX: Might be the kind of news this Firm has long needed. (I.e., no more silly promos, ads, etc. ---- now, serious business.)
πŸ‘οΈ0
PinkPennies PinkPennies 3 months ago
MGRX nice news https://finance.yahoo.com/news/mangorx-announces-strategic-partnership-expansion-121500806.html
πŸ‘οΈ0
valleybenedetto valleybenedetto 4 months ago
Mango written up by JP Morgan Fund!

https://athletechnews.com/jp-morgan-targets-weight-loss-drugs-with-500m-fund/?s=09
👍️ 1 💯 1
Golden Cross Golden Cross 4 months ago
$MGRX MangoRx to Introduce β€œMOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances https://www.stocktitan.net/news/MGRX/mango-rx-to-introduce-mojo-pharmaceutical-compounded-formula-xetrg1zk54sn.html
πŸ‘οΈ0
Carjockey2 Carjockey2 5 months ago
Haaaaa..

I am the new crypto coin gal..

Lol
πŸ‘οΈ0
valleybenedetto valleybenedetto 5 months ago
Trade em up. No more marriages
πŸ‘οΈ0
Carjockey2 Carjockey2 5 months ago
Nice news but I'm done with this one.

πŸ‘οΈ0
valleybenedetto valleybenedetto 5 months ago
Nice news today. Partnered with CrakMedia..same firm that brought BlueChew to 200m revs
πŸ‘οΈ0
Carjockey2 Carjockey2 5 months ago
Again...

Don't include me on your posts like you did all day today..

Does that work for you..works for me..

Cyber stalking is illegal...

Back to your 4 jobs you go..

πŸ‘οΈ0
crowin crowin 5 months ago
Again my point that everything is about you!

Get back with the family, they miss you!


Please keep your post about MGRX.
πŸ‘οΈ0
Carjockey2 Carjockey2 5 months ago
LMAO

You have had time to stalk me for 10 years..YES 10 years..


I am happily retired..

No 4 jobs for me..

Follow the right traders you won't have to work 4 jobs..

After following me for 10 years you should be happily retired with your family what have you been doing wrong







πŸ‘οΈ0
crowin crowin 5 months ago
I Have a life and do not hang out around here allday, just mornings.

What is wrong with that ?

Take care of the family like i do.

4 business and family is my priority...
Whats yours?
πŸ‘οΈ0
crowin crowin 5 months ago
Everything you post is about you. Stop it!

You missed out today for a quick buck.

Whats next?

Stop stalking me when I make money without you!
Go and enjoy the Grand baby!

Granny, will you please focus on me and not IHUB!

I miss you granny......
πŸ‘οΈ0
Carjockey2 Carjockey2 5 months ago
If you I really owned shares here you wouldn't be posting five times to me on a board you'd be celebrating, so I guess we know what's up..

We all know you stalk me but that's even crazy..
πŸ‘οΈ0
Carjockey2 Carjockey2 5 months ago
Lolzzzz

Awesome day here..

$MGRX


What's weee??

This was your last post in February..lol

Reverse Stock split to risky here

Silly bird.. is it difficult pretending you own shares of something you hated when it runs???
πŸ‘οΈ0
Carjockey2 Carjockey2 5 months ago
Great day everybody congratulations..

$MGRX got a bona..

😉
πŸ‘οΈ0
Invest-in-America Invest-in-America 5 months ago
MGRX: Are my MGRX shares 'rising-from-the-ashes' now, following a rather disappointing Close today??? (At 32% UP in the Post-M right now, might be so.)
πŸ‘οΈ0
Invest-in-America Invest-in-America 5 months ago
MGRX: Hey "Invest-in-America", CLOWN!! Why don't you flush your pet PUSSYCAT down that toilet, FOOL!!! (Which is likely the ONLY 'pussy' you ever got, STUPID!!) WHY??? Because our MGRX COMEBACK is gonna make Tom Brady's look like those stupid 'BUCKS' of Florida never even scored ONE POINT in that game!!!
πŸ‘οΈ0
Invest-in-America Invest-in-America 5 months ago
MGRX: See today's final 'CHART', below!!

πŸ‘οΈ0
Invest-in-America Invest-in-America 5 months ago
MGRX: Come on, you dead-cat, BOUNCE!!! For the sake of us BIG-FAT-&-GREASY Amerikanos!!! And heck, you have one pill to make mens' DICKS big & fat --- and now another pill to make their OBESITY-BODIES "slim & trim"!!! Why not do BOTH in just one, tasty, fat pill???!!!

////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
And see BELOW, what my own 'Personal Financial Planner' said to me early today, when I asked him what he thought about me tossin' some bucks at MGRX stock ---
πŸ‘οΈ0
pumpnass pumpnass 5 months ago
No doubt, over 200 million shares traded and it can’t even get out of its own way now. All this volume it should be over 5 dollars but because the scam CEO made so many bad deals the funders are having a field day with the volatility
πŸ‘οΈ0
CashCowMoo CashCowMoo 5 months ago
I would take the money and run too based on past performance (no pun intended)
πŸ‘οΈ0
pumpnass pumpnass 5 months ago
Yea definitely did but if they knew what’s good for them take the money and run. That’s what I would do if I was still holding this trash
πŸ‘οΈ0
CashCowMoo CashCowMoo 5 months ago
Well, if thats the case at least some people got some good flips in.
πŸ‘οΈ0
pumpnass pumpnass 5 months ago
It will be back in the garage before you know it. This company is a complete scam starting with the CEO
πŸ‘οΈ0
Invest-in-America Invest-in-America 5 months ago
MGRX: From their PR today ---
https://www.globenewswire.com/news-release/2024/05/21/2885580/0/en/MangoRx-to-Introduce-Oral-Semaglutide-and-Tirzepatide-in-Response-to-Increasing-Patient-Demand-for-GLP-1-Medications.html
"We are thrilled to introduce 'Slim' and 'Trim', MangoRx's oral formulations of Semaglutide and Tirzepatide, to the weight loss market", said Jacob Cohen, CEO and Co-Founder of MangoRx. "Our goal is to provide patients with a convenient (vs. injections) and effective way to manage their weight and improve their overall health. We believe that these oral formulations have the potential to significantly impact the lives of millions of people worldwide." (Emphases & parenthesis added.)
///////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
πŸ‘οΈ0
CashCowMoo CashCowMoo 5 months ago
Looks like this has risen from the dead!
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock